A61P

SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

This subclass covers therapeutic activity of chemical compounds or medicinal preparations already classified as such in subclasses A61K or C12N, or in classes C01, C07 or C08

In this subclass, the term "drugs" includes chemical compounds or compositions with therapeutic activity.

In this subclass, therapeutic activity is classified in all appropriate places to the extent of all the different therapeutic activities stated in the claims and also significantly disclosed as examples in the disclosure.

Attention is drawn to cases where the subject of the invention concerns only specific therapeutic activity of chemical compounds or medical preparations, and the chemical structure, compound, mixture or composition of this subject of the invention is known. In such cases, classification is made in both subclass A61K and subclass A61P as invention information. In addition, if the chemical structure, compound, mixture or composition or any individual ingredient of a mixture or composition is considered to represent information of interest for search, it may also be classified as additional information. There is no classification in C01, C07, C08, C12N as additional information in CPC if the chemical structure, compound, mixture or composition or any individual ingredient of a mixture or composition is known and classification is made in both subclass A61K and subclass A61P as invention information.

The classification symbols of this subclass are not listed first when assigned to patent documents.

A61P1/00

Drugs for disorders of the alimentary tract or the digestive system

A61P1/02

Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

A61P1/04

for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

A61P1/06

Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia

A61P1/08

for nausea, cinetosis or vertigo

Antiemetics

A61P1/10

Laxatives

A61P1/12

Antidiarrhoeals

A61P1/14

Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

A61P1/16

for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

A61P1/18

for pancreatic disorders, e.g. pancreatic enzymes

A61P3/00

Drugs for disorders of the metabolism of the blood or the extracellular fluid A61P7/00

A61P3/02

Nutrients, e.g. vitamins, minerals

A61P3/04

Anorexiants

Antiobesity agents

A61P3/06

Antihyperlipidemics

A61P3/08

for glucose homeostasis pancreatic hormones A61P5/48

A61P3/10

for hyperglycaemia, e.g. antidiabetics

A61P3/12

for electrolyte homeostasis

A61P3/14

for calcium homeostasis vitamin D A61P3/02; parathyroid hormones A61P5/18; calcitonin A61P5/22; osteoporosis A61P19/10; bone metastasis A61P35/04

A61P5/00

Drugs for disorders of the endocrine system

A61P5/02

of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

A61P5/04

for decreasing, blocking or antagonising the activity of the hypothalamic hormones

A61P5/06

of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

A61P5/08

for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

A61P5/10

of the posterior pituitary hormones, e.g. oxytocin, ADH

A61P5/12

for decreasing, blocking or antagonising the activity of the posterior pituitary hormones

A61P5/14

of the thyroid hormones, e.g. T3, T4

A61P5/16

for decreasing, blocking or antagonising the activity of the thyroid hormones

A61P5/18

of the parathyroid hormones

A61P5/20

for decreasing, blocking or antagonising the activity of PTH

A61P5/22

for decreasing, blocking or antagonising the activity of calcitonin

A61P5/24

of the sex hormones

A61P5/26

Androgens

A61P5/28

Antiandrogens

A61P5/30

Oestrogens

A61P5/32

Antioestrogens

A61P5/34

Gestagens

A61P5/36

Antigestagens

A61P5/38

of the suprarenal hormones

A61P5/40

Mineralocorticosteroids, e.g. aldosterone

Drugs increasing or potentiating the activity of mineralocorticosteroids

A61P5/42

for decreasing, blocking or antagonising the activity of mineralocorticosteroids

A61P5/44

Glucocorticosteroids

Drugs increasing or potentiating the activity of glucocorticosteroids

A61P5/46

for decreasing, blocking or antagonising the activity of glucocorticosteroids

A61P5/48

of the pancreatic hormones

A61P5/50

for increasing or potentiating the activity of insulin

A61P7/00

Drugs for disorders of the blood or the extracellular fluid

A61P7/02

Antithrombotic agents

Anticoagulants

Platelet aggregation inhibitors

A61P7/04

Antihaemorrhagics

Procoagulants

Haemostatic agents

Antifibrinolytic agents

A61P7/06

Antianaemics

A61P7/08

Plasma substitutes

Perfusion solutions

Dialytics or haemodialytics

Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock artificial tears A61P27/04

A61P7/10

Antioedematous agents

Diuretics

A61P7/12

Antidiuretics, e.g. drugs for diabetes insipidus ADH A61P5/10

A61P9/00

Drugs for disorders of the cardiovascular system

A61P9/02

Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

A61P9/04

Inotropic agents, i.e. stimulants of cardiac contraction

Drugs for heart failure

A61P9/06

Antiarrhythmics

A61P9/08

Vasodilators for multiple indications

A61P9/10

for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

A61P9/12

Antihypertensives

A61P9/14

Vasoprotectives

Antihaemorrhoidals

Drugs for varicose therapy

Capillary stabilisers

A61P11/00

Drugs for disorders of the respiratory system

A61P11/02

Nasal agents, e.g. decongestants

A61P11/04

for throat disorders

A61P11/06

Antiasthmatics

A61P11/08

Bronchodilators

A61P11/10

Expectorants

A61P11/12

Mucolytics

A61P11/14

Antitussive agents

A61P11/16

Central respiratory analeptics

A61P13/00

Drugs for disorders of the urinary system

A61P13/02

of urine or of the urinary tract, e.g. urine acidifiers

A61P13/04

for urolithiasis

A61P13/06

Anti-spasmodics

A61P13/08

of the prostate

A61P13/10

of the bladder

A61P13/12

of the kidneys

A61P15/00

Drugs for genital or sexual disorders for disorders of sex hormones A61P5/24

Contraceptives

A61P15/02

for disorders of the vagina

A61P15/04

for inducing labour or abortion

Uterotonics

A61P15/06

Antiabortive agents

Labour repressants

A61P15/08

for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

A61P15/10

for impotence

A61P15/12

for climacteric disorders

A61P15/14

for lactation disorders, e.g. galactorrhoea

A61P15/16

Masculine contraceptives

A61P15/18

Feminine contraceptives

A61P17/00

Drugs for dermatological disorders

A61P17/02

for treating wounds, ulcers, burns, scars, keloids, or the like

A61P17/04

Antipruritics

A61P17/06

Antipsoriatics

A61P17/08

Antiseborrheics

A61P17/10

Anti-acne agents

A61P17/12

Keratolytics, e.g. wart or anti-corn preparations

A61P17/14

for baldness or alopecia

A61P17/16

Emollients or protectives, e.g. against radiation

A61P17/18

Antioxidants, e.g. antiradicals preparations for protection against sunlight A61Q17/00

A61P19/00

Drugs for skeletal disorders

A61P19/02

for joint disorders, e.g. arthritis, arthrosis

A61P19/04

for non-specific disorders of the connective tissue

A61P19/06

Antigout agents, e.g. antihyperuricemic or uricosuric agents

A61P19/08

for bone diseases, e.g. rachitism, Paget's disease

A61P19/10

for osteoporosis

A61P21/00

Drugs for disorders of the muscular or neuromuscular system

A61P21/02

Muscle relaxants, e.g. for tetanus or cramps

A61P21/04

for myasthenia gravis

A61P21/06

Anabolic agents androgens A61P5/26

A61P23/00

Anaesthetics

A61P23/02

Local anaesthetics

A61P25/00

Drugs for disorders of the nervous system

A61P25/02

for peripheral neuropathies

A61P25/04

Centrally acting analgesics, e.g. opioids

A61P25/06

Antimigraine agents

A61P25/08

Antiepileptics

Anticonvulsants

A61P25/10

for petit-mal

A61P25/12

for grand-mal

A61P25/14

for treating abnormal movements, e.g. chorea, dyskinesia

A61P25/16

Anti-Parkinson drugs

A61P25/18

Antipsychotics, i.e. neuroleptics

Drugs for mania or schizophrenia

A61P25/20

Hypnotics

Sedatives

A61P25/22

Anxiolytics

A61P25/24

Antidepressants

A61P25/26

Psychostimulants, e.g. nicotine, cocaine

A61P25/28

for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

A61P25/30

for treating abuse or dependence

A61P25/32

Alcohol-abuse

A61P25/34

Tobacco-abuse

A61P25/36

Opioid-abuse

A61P27/00

Drugs for disorders of the senses

A61P27/02

Ophthalmic agents

A61P27/04

Artificial tears

Irrigation solutions

A61P27/06

Antiglaucoma agents or miotics

A61P27/08

Mydriatics or cycloplegics

A61P27/10

for accommodation disorders, e.g. myopia

A61P27/12

for cataracts

A61P27/14

Decongestants or antiallergics

A61P27/16

Otologicals

A61P29/00

Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents

Non-steroidal antiinflammatory drugs [NSAID]

A61P29/02

without antiinflammatory effect

A61P31/00

Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P31/02

Local antiseptics

A61P31/04

Antibacterial agents

A61P31/06

for tuberculosis

A61P31/08

for leprosy

A61P31/10

Antimycotics

A61P31/12

Antivirals

A61P31/14

for RNA viruses

A61P31/16

for influenza or rhinoviruses

A61P31/18

for HIV

A61P31/20

for DNA viruses

A61P31/22

for herpes viruses

A61P33/00

Antiparasitic agents

A61P33/02

Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

A61P33/04

Amoebicides

A61P33/06

Antimalarials

A61P33/08

for Pneumocystis carinii

A61P33/10

Anthelmintics

A61P33/12

Schistosomicides

A61P33/14

Ectoparasiticides, e.g. scabicides

A61P35/00

Antineoplastic agents

A61P35/02

specific for leukemia

A61P35/04

specific for metastasis

A61P37/00

Drugs for immunological or allergic disorders

A61P37/02

Immunomodulators

A61P37/04

Immunostimulants

A61P37/06

Immunosuppressants, e.g. drugs for graft rejection

A61P37/08

Antiallergic agents antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14

A61P39/00

General protective or antinoxious agents

A61P39/02

Antidotes

A61P39/04

Chelating agents

A61P39/06

Free radical scavengers or antioxidants

A61P41/00

Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

A61P43/00

Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Classification is only made in this group when a specific therapeutic activity for a chemical compound or medicinal preparation has been clearly disclosed, the specific therapeutic activity not being appropriate to any of groups A61P1/00 - A61P41/00.